29 Sep 2021 Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC) Member news
23 Sep 2021 Biocartis announces restart of its high-throughput cartridge manufacturing line Member news
22 Sep 2021 Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer Member news
22 Sep 2021 Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study Member news
17 Sep 2021 Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
